Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma

NCT01378871 is registered in ClinicalTrials.gov with Amit Verma as lead sponsor.

NCT NCT01378871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01378871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Lead sponsor
Amit Verma
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2010
Completion date
January 31, 2013
Enrollment
1 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

adult t cell leukemia, adult t cell lymphoma